Arcellx, Inc. — Investor Relations & Filings
Arcellx, Inc. is a clinical-stage biotechnology company that develops immunotherapies for patients with cancer and autoimmune diseases. The company is focused on reimagining cell therapy through its proprietary D-Domain technology. This technology is the foundation for its two main platforms: ddCAR, which produces autologous and allogeneic CAR-T therapies, and ARC-SparX, which involves controllable and adaptable cell therapies. Arcellx's lead investigational product, CART-ddBCMA, is in clinical development for the treatment of relapsed or refractory multiple myeloma. The company aims to create therapies that are safer, more effective, and more broadly accessible.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Major Shareholding Notification 2025 | 2025-09-08 | English | |
| Director's Dealing 2025 | 2025-08-29 | English | |
| Major Shareholding Notification 2025 | 2025-08-15 | English | |
| 4 | 2025-08-15 | English | |
| Major Shareholding Notification 2025 | 2025-08-14 | English | |
| 10-Q | 2025-08-07 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 13200504 | Major Shareholding Notification 2025 | 2025-09-08 | English | ||
| 13200505 | Director's Dealing 2025 | 2025-08-29 | English | ||
| 13200506 | Major Shareholding Notification 2025 | 2025-08-15 | English | ||
| 13200507 | 4 | 2025-08-15 | English | ||
| 13200508 | Major Shareholding Notification 2025 | 2025-08-14 | English | ||
| 13200510 | 10-Q | 2025-08-07 | English | ||
| 13200512 | 8-K | 2025-08-07 | English | ||
| 13200513 | 4 | 2025-06-11 | English | ||
| 13200514 | Regulatory Filings 2025 | 2025-06-10 | English | ||
| 13200515 | 4 | 2025-05-30 | English | ||
| 13200516 | Director's Dealing 2025 | 2025-05-30 | English | ||
| 13200517 | Director's Dealing 2025 | 2025-05-30 | English | ||
| 13200518 | Director's Dealing 2025 | 2025-05-30 | English | ||
| 13200519 | Director's Dealing 2025 | 2025-05-30 | English | ||
| 13200520 | 4 | 2025-05-30 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Arcellx, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/31114/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=31114 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=31114 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=31114 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 31114}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Arcellx, Inc. (id: 31114)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.